Search Results - Adrian Box
- Showing 1 - 5 results of 5
-
1
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for <i>EGFR</i> Mutation-Positive Patients Treated with First-Line Osimertinib by Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y. Cheung, Vishal Navani
Published in Current Oncology (2024-04-01)Get full text
Article -
2
Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers by Markus Eszlinger, Paul Stewardson, John B McIntyre, Adrian Box, Moosa Khalil, Martin Hyrcza, Konstantin Koro, Dean Ruether, Jiahui Wu, Ralf Paschke
Published in European Thyroid Journal (2023-01-01)Get full text
Article -
3
Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort by Amanda J. W. Gibson, Adrian Box, Winson Y. Cheung, Michelle L. Dean, Anifat A. Elegbede, Desiree Hao, Aliyah Pabani, Randeep Sangha, Dafydd Gwyn Bebb
Published in Current Oncology (2022-03-01)Get full text
Article -
4
Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors by Amanda J.W. Gibson, BSc (Hons), Adrian Box, MD, PhD, Michelle L. Dean, BSc, Anifat A. Elegbede, MSc, Desiree Hao, MD, Randeep Sangha, MD, D. Gwyn Bebb, BMBCh, PhD
Published in JTO Clinical and Research Reports (2021-04-01)Get full text
Article -
5
Consensus Recommendations to Optimize the Detection and Reporting of <i>NTRK</i> Gene Fusions by RNA-Based Next-Generation Sequencing by Tracy L. Stockley, Bryan Lo, Adrian Box, Andrea Gomez Corredor, John DeCoteau, Patrice Desmeules, Harriet Feilotter, Daria Grafodatskaya, Cynthia Hawkins, Weei Yuarn Huang, Iyare Izevbaye, Guylaine Lepine, Andreas I. Papadakis, Paul C. Park, Brandon S. Sheffield, Danh Tran-Thanh, Stephen Yip, Ming Sound Tsao
Published in Current Oncology (2023-03-01)Get full text
Article